These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 30656969)
61. [Inflammatory breast cancer: 38 cases clinical report]. Huang J; Zhang P; Liu P; Ou GF; Wang ZP; Xu BH Ai Zheng; 2002 Aug; 21(8):888-91. PubMed ID: 12478900 [TBL] [Abstract][Full Text] [Related]
62. A single-center experience with inflammatory breast cancer, 1985-2003. Smoot RL; Koch CA; Degnim AC; Sterioff S; Donohue JH; Grant CS; Barnes SA; Gullerud RE; Hobday TJ; Farley DR Arch Surg; 2006 Jun; 141(6):567-72; discussion 572-3. PubMed ID: 16785357 [TBL] [Abstract][Full Text] [Related]
63. Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation. Janoray G; Pointreau Y; Garaud P; Chapet S; Alfonsi M; Sire C; Jadaud E; Calais G J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26681800 [TBL] [Abstract][Full Text] [Related]
64. Induction Therapy or Upfront Surgery? The Debate Rages On: Reply. Rhodin KE; Raman V; D'Amico TA Ann Thorac Surg; 2021 Jun; 111(6):2085-2086. PubMed ID: 33621551 [No Abstract] [Full Text] [Related]
65. Systematic Review and Meta-Analysis of Treatment Effects on Survival in Patients with Inflammatory Breast Cancer. Bahrami P; Moayeri H; Moradi G; Nouri E; Moradi Y Asian Pac J Cancer Prev; 2023 Oct; 24(10):3335-3343. PubMed ID: 37898836 [TBL] [Abstract][Full Text] [Related]
66. Induction therapy in recurrent head and neck squamous cell carcinoma: is it time to consider response as a determinant of treatment selection? Tasoulas J; Sheth S Transl Cancer Res; 2023 Apr; 12(4):697-700. PubMed ID: 37180661 [No Abstract] [Full Text] [Related]
67. Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer. Akay CL; Ueno NT; Chisholm GB; Hortobagyi GN; Woodward WA; Alvarez RH; Bedrosian I; Kuerer HM; Hunt KK; Huo L; Babiera GV Cancer; 2014 May; 120(9):1319-28. PubMed ID: 24510381 [TBL] [Abstract][Full Text] [Related]
68. Once-daily radiation therapy for inflammatory breast cancer. Brown L; Harmsen W; Blanchard M; Goetz M; Jakub J; Mutter R; Petersen I; Rooney J; Stauder M; Yan E; Laack N Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):997-1003. PubMed ID: 24721591 [TBL] [Abstract][Full Text] [Related]
69. Initial response to chemotherapy, not delay in diagnosis, predicts overall survival in inflammatory breast cancer cases. Hoffman HJ; Khan A; Ajmera KM; Zolfaghari L; Schenfeld JR; Levine PH Am J Clin Oncol; 2014 Aug; 37(4):315-21. PubMed ID: 23241503 [TBL] [Abstract][Full Text] [Related]
70. Circulating tumor cells in newly diagnosed inflammatory breast cancer. Mego M; Giordano A; De Giorgi U; Masuda H; Hsu L; Giuliano M; Fouad TM; Dawood S; Ueno NT; Valero V; Andreopoulou E; Alvarez RH; Woodward WA; Hortobagyi GN; Cristofanilli M; Reuben JM Breast Cancer Res; 2015 Jan; 17(1):2. PubMed ID: 25572591 [TBL] [Abstract][Full Text] [Related]
71. Clinical Response to Induction Chemotherapy Predicts Outcome after Combined-Modality Therapy in Inflammatory Breast Cancer. Loi M; Dunant A; Ghith S; Cascales-Garcia AM; Mazouni C; Pistilli B; Mathieu MC; Deutsch E; Arriagada R; Rivera S Cancer Invest; 2019; 37(1):29-38. PubMed ID: 30656969 [TBL] [Abstract][Full Text] [Related]